A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Clinical trial NCT07082829 · RECRUITING

Trial details

NCT number: NCT07082829
Sponsor: Centessa Pharmaceuticals (UK) Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Excessive Daytime Sleepiness

Start date: 2025-06-30
Primary completion: 2026-06-15
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.